Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2016-12-22 Board/Management Inform…
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
BOVIE FORM 8-K RE: RESIGNATIONS
Board/Management Information Classification · 100% confidence The document is a Form 8-K filing with the SEC, dated December 19, 2016, reporting the resignation of two directors from the company's Board of Directors and the appointment of a new chairman for the Compensation Committee and member of the Audit Committee. The content focuses on changes in the board and senior management positions. There are no financial statements or detailed financial data present. The document is relatively short (3209 characters) and is a current report on corporate governance changes. According to the filing definitions, announcements of changes in the company's board or senior management fall under 'Board/Management Information' (MANG).
2016-12-22 English
Major Shareholding Notification 2016
Major Shareholding Notification
2016-11-23 English
Major Shareholding Notification 2016
Major Shareholding Notification
2016-11-22 English
BOVIE 8-K RE: POST-CLOSING
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated November 18, 2016, reporting the completion of a public offering of common stock by Bovie Medical Corporation. It details the number of shares offered, the offering price, net proceeds to the company, and distinguishes between primary and secondary offerings. This is a current report on a financing event, specifically a capital raising activity. The document is relatively short (2744 characters) and contains substantive information about the financing transaction, not just an announcement or a certification. Therefore, it fits the category of Capital/Financing Update (CAP).
2016-11-18 English
8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The content describes the entry into a material definitive agreement related to an underwriting agreement for a public offering of common stock. It includes details about the offering size, pricing, and parties involved. There is also mention of a press release announcing the pricing of the offerings. The document does not contain financial statements or detailed financial analysis but rather announces a financing event. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes.
2016-11-10 English
424B7
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(7) under a registration statement, describing the offering of 1,500,000 shares of common stock by selling stockholders. It includes detailed information about the offering price, underwriting, risk factors, use of proceeds, selling stockholders, dilution, and legal matters. The document is clearly a securities offering document related to capital raising activities. It is not a financial report, earnings release, management discussion, or any other type of corporate report. It is a detailed disclosure document for a stock offering, which fits the definition of a Capital/Financing Update (CAP). The length and content confirm it is not a brief announcement or a regulatory filing fallback. Therefore, the correct classification is CAP with high confidence.
2016-11-10 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.